Found: 24
Select item for more details and to access through your institution.
Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30585-0
- By:
- Publication type:
- Article
Impact of multidisciplinary collaborative pharmaceutical care on knowledge, adherence, and efficacy of hormone therapy in climacteric women.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1273, doi. 10.2147/PPA.S165238
- By:
- Publication type:
- Article
Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.772504
- By:
- Publication type:
- Article
Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.772504
- By:
- Publication type:
- Article
Isolation, Screening, and Active Metabolites Identification of Anti- Vibrio Fungal Strains Derived From the Beibu Gulf Coral.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.930981
- By:
- Publication type:
- Article
Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1729, doi. 10.1177/1352458519881761
- By:
- Publication type:
- Article
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 8, p. 1025, doi. 10.1177/1352458514557986
- By:
- Publication type:
- Article
Building a New Framework for Urban Parking Facilities Research with Quality Improvement: The Case of Chongqing, China.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 1, p. 607, doi. 10.3390/ijerph20010607
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsingremitting multiple sclerosis.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 7, doi. 10.1186/s12883-014-0240-x
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2230439, doi. 10.1001/jamanetworkopen.2022.30439
- By:
- Publication type:
- Article
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis The CONNECT Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. 1, doi. 10.1001/jamanetworkopen.2022.30439
- By:
- Publication type:
- Article
Dragon's Blood-Loaded Mesoporous Silica Nanoparticles for Rapid Hemostasis and Antibacterial Activity.
- Published in:
- Molecules, 2024, v. 29, n. 8, p. 1888, doi. 10.3390/molecules29081888
- By:
- Publication type:
- Article
Bornyl acetate extracted from Sharen (Fructus Amomi) inhibits proliferation, invasion and induces apoptosis by suppressing phosphatidylinositol-3-kinase/protein kinase B signaling in colorectal cancer.
- Published in:
- Journal of Traditional Chinese Medicine, 2023, v. 43, n. 6, p. 1081, doi. 10.19852/j.cnki.jtcm.20231018.002
- By:
- Publication type:
- Article
Use of Ionic Liquids as Solvents for Epoxidation Reactions Catalysed by a Chiral Katsuki-Type Salen Complex: Enhanced Reactivity and Recovery of Catalyst.
- Published in:
- Catalysis Letters, 2004, v. 98, n. 2/3, p. 95, doi. 10.1007/s10562-004-7921-9
- By:
- Publication type:
- Article
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 9, p. 1778, doi. 10.1007/s00415-016-8182-4
- By:
- Publication type:
- Article
Analysis of blood testing indicators in HIV patients co-infected with different genotypes of HCV in Kunming area of Yunnan Province.
- Published in:
- China Tropical Medicine, 2024, v. 24, n. 3, p. 252, doi. 10.13604/j.cnki.46-1064/r.2024.03.04
- By:
- Publication type:
- Article
A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 6, p. 798, doi. 10.1177/0091270011407068
- By:
- Publication type:
- Article
Hemoglobin Maintenance in Diabetic and Nondiabetic Dialysis Patients with C.E.R.A. Every 2 or 4 Weeks: A Pooled Phase III Analysis.
- Published in:
- Diabetes, 2007, v. 56, p. A197
- By:
- Publication type:
- Article
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2016, v. 43, n. 4, p. 371, doi. 10.1007/s10928-016-9477-x
- By:
- Publication type:
- Article
Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCE.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 1, p. 41, doi. 10.1177/1756285616676065
- By:
- Publication type:
- Article
Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 8, p. 1005, doi. 10.1002/jcph.883
- By:
- Publication type:
- Article